Inhaled Nintedanib is Well-Tolerated and Delivers Key Pharmacokinetic Parameters Required to Treat Bleomycin-Induced Pulmonary Fibrosis

Publication date: Available online 22 August 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Mark W. Surber, Steve Beck, Stephen Pham, Angela T. Marsden, Senthil K. Gandi, James Baily, Mary C. McElroy
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research